These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28365448)

  • 21. Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells.
    Li X; Shiratsuchi T; Chen G; Dellabona P; Casorati G; Franck RW; Tsuji M
    J Immunol; 2009 Oct; 183(7):4415-21. PubMed ID: 19734232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient synthesis of alpha-C-galactosyl ceramide immunostimulants: use of ethylene-promoted olefin cross-metathesis.
    Chen G; Schmieg J; Tsuji M; Franck RW
    Org Lett; 2004 Oct; 6(22):4077-80. PubMed ID: 15496103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of all stereoisomers of KRN7000, the CD1d-binding NKT cell ligand.
    Park JJ; Lee JH; Ghosh SC; Bricard G; Venkataswamy MM; Porcelli SA; Chung SK
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3906-9. PubMed ID: 18586489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New CD1d agonists: synthesis and biological activity of 6″-triazole-substituted α-galactosyl ceramides.
    Jervis PJ; Graham LM; Foster EL; Cox LR; Porcelli SA; Besra GS
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4348-52. PubMed ID: 22652050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.
    Sullivan BA; Nagarajan NA; Wingender G; Wang J; Scott I; Tsuji M; Franck RW; Porcelli SA; Zajonc DM; Kronenberg M
    J Immunol; 2010 Jan; 184(1):141-53. PubMed ID: 19949076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and evaluation of α-galactopyranosylceramide mimics promoting Th2 cytokines production.
    Hu L; Zhao C; Ma J; Jing Y; Du Y
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1357-1362. PubMed ID: 30935793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The total synthesis of immunostimulant α-galactosylceramides from naturally configured α-galactoside raffinose.
    Zhang Z; Zhao W; Wang B; Xia C; Zhang W; Wang PG
    Org Lett; 2011 Sep; 13(17):4530-3. PubMed ID: 21815670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.
    Hunault J; Diswall M; Frison JC; Blot V; Rocher J; Marionneau-Lambot S; Oullier T; Douillard JY; Guillarme S; Saluzzo C; Dujardin G; Jacquemin D; Graton J; Le Questel JY; Evain M; Lebreton J; Dubreuil D; Le Pendu J; Pipelier M
    J Med Chem; 2012 Feb; 55(3):1227-41. PubMed ID: 22243602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells.
    Tashiro T; Sekine-Kondo E; Shigeura T; Nakagawa R; Inoue S; Omori-Miyake M; Chiba T; Hongo N; Fujii S; Shimizu K; Yoshiga Y; Sumida T; Mori K; Watarai H; Taniguchi M
    Int Immunol; 2010 Apr; 22(4):319-28. PubMed ID: 20181652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
    Silk JD; Salio M; Reddy BG; Shepherd D; Gileadi U; Brown J; Masri SH; Polzella P; Ritter G; Besra GS; Jones EY; Schmidt RR; Cerundolo V
    J Immunol; 2008 May; 180(10):6452-6. PubMed ID: 18453560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-c-galactosylceramides: synthesis and immunology.
    Franck RW; Tsuji M
    Acc Chem Res; 2006 Oct; 39(10):692-701. PubMed ID: 17042469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel synthesis of alpha-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity.
    Lee A; Farrand KJ; Dickgreber N; Hayman CM; Jürs S; Hermans IF; Painter GF
    Carbohydr Res; 2006 Dec; 341(17):2785-98. PubMed ID: 17014832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunostimulatory activities of monoglycosylated alpha-D-pyranosylceramides.
    Uchimura A; Shimizu T; Morita M; Ueno H; Motoki K; Fukushima H; Natori T; Koezuka Y
    Bioorg Med Chem; 1997 Dec; 5(12):2245-9. PubMed ID: 9459022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological activity of alpha-galactosyl ceramide KRN7000 and galactosyl (alpha1-->2) galactosyl ceramide.
    Veerapen N; Brigl M; Garg S; Cerundolo V; Cox LR; Brenner MB; Besra GS
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4288-91. PubMed ID: 19502056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E and Z alpha-C-galactosylceramides by Julia-Lythgoe-Kocienski chemistry: a test of the receptor-binding model for glycolipid immunostimulants.
    Chen G; Chien M; Tsuji M; Franck RW
    Chembiochem; 2006 Jul; 7(7):1017-22. PubMed ID: 16795118
    [No Abstract]   [Full Text] [Related]  

  • 36. Total synthesis of α-1C-galactosylceramide, an immunostimulatory C-glycosphingolipid, and confirmation of the stereochemistry in the first-generation synthesis.
    Liu Z; Byun HS; Bittman R
    J Org Chem; 2011 Nov; 76(21):8588-98. PubMed ID: 21958232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RCAI-17, 22, 24-26, 29, 31, 34-36, 38-40, and 88, the analogs of KRN7000 with a sulfonamide linkage: their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines.
    Tashiro T; Hongo N; Nakagawa R; Seino K; Watarai H; Ishii Y; Taniguchi M; Mori K
    Bioorg Med Chem; 2008 Oct; 16(19):8896-906. PubMed ID: 18790646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
    Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
    J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
    Kikuchi A; Nieda M; Schmidt C; Koezuka Y; Ishihara S; Ishikawa Y; Tadokoro K; Durrant S; Boyd A; Juji T; Nicol A
    Br J Cancer; 2001 Sep; 85(5):741-6. PubMed ID: 11531261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of NBD-alpha-galactosylceramide and its immunologic properties.
    Sakai T; Ehara H; Koezuka Y
    Org Lett; 1999 Aug; 1(3):359-61. PubMed ID: 10822576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.